Literature DB >> 20228421

Effect of quercetin on paraoxonase 1 activity--studies in cultured cells, mice and humans.

C Boesch-Saadatmandi1, S Egert, C Schrader, X Coumoul, X Coumol, R Barouki, M J Muller, S Wolffram, G Rimbach.   

Abstract

There is increasing evidence that the HDL-associated enzyme paraoxonase 1 (PON1) may have a protective function in the atherosclerotic process. An enhancement of PON1 activity by dietary factors including flavonoids is therefore of interest. Quercetin, a flavonol frequently present in fruits and vegetables has been shown to induce PON1 in cultured liver cells, but the in vivo efficacy of a dietary quercetin supplementation has yet not been evaluated. To this end, we fed laboratory mice quercetin-enriched diets with quercetin concentrations ranging from 0.05 to 2 mg/g diet for 6 weeks and determined the expression of the hepatic PON1 gene and its protein levels. Since we could establish a moderate but significant induction of PON1 mRNA levels by dietary quercetin in mice, we aimed to proof whether healthy human volunteers, given graded supplementary quercetin (50, 100 or 150 mg/day) for two weeks, would respond with likewise enhanced plasma paraoxonase activities. However, PON1 activity towards phenylacetate and paraoxon was not changed following quercetin supplementation in humans. Differences between mice and humans regarding the PON1 inducing activity of quercetin may be related to differences in quercetin metabolism. In mice, unlike in humans, a large proportion of quercetin is methylated to isorhamnetin which exhibits, according to our reporter gene data in cultured liver cells, a potent PON1 inducing activity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20228421

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  16 in total

1.  Higher plasma quercetin levels following oral administration of an onion skin extract compared with pure quercetin dihydrate in humans.

Authors:  Constanze Burak; Verena Brüll; Peter Langguth; Benno F Zimmermann; Birgit Stoffel-Wagner; Udo Sausen; Peter Stehle; Siegfried Wolffram; Sarah Egert
Journal:  Eur J Nutr       Date:  2015-10-20       Impact factor: 5.614

Review 2.  Pharmacogenetics of paraoxonase activity: elucidating the role of high-density lipoprotein in disease.

Authors:  Daniel Seung Kim; Judit Marsillach; Clement E Furlong; Gail P Jarvik
Journal:  Pharmacogenomics       Date:  2013-09       Impact factor: 2.533

Review 3.  Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: the hunt goes on.

Authors:  Lucio G Costa; Gennaro Giordano; Clement E Furlong
Journal:  Biochem Pharmacol       Date:  2010-11-18       Impact factor: 5.858

Review 4.  Paraoxonases: metabolic role and pharmacological projection.

Authors:  Carlos Moya; Salvador Máñez
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-02-06       Impact factor: 3.000

5.  Treatment with Isorhamnetin Protects the Brain Against Ischemic Injury in Mice.

Authors:  Jin-Jing Zhao; Jin-Qing Song; Shu-Yi Pan; Kai Wang
Journal:  Neurochem Res       Date:  2016-05-09       Impact factor: 3.996

Review 6.  Which sources of flavonoids: complex diets or dietary supplements?

Authors:  Sarah Egert; Gerald Rimbach
Journal:  Adv Nutr       Date:  2011-01-10       Impact factor: 8.701

Review 7.  The human paraoxonase gene cluster as a target in the treatment of atherosclerosis.

Authors:  Zhi-Gang She; Hou-Zao Chen; Yunfei Yan; Hongliang Li; De-Pei Liu
Journal:  Antioxid Redox Signal       Date:  2011-10-18       Impact factor: 8.401

Review 8.  Effects of Dietary Flavonoids on Reverse Cholesterol Transport, HDL Metabolism, and HDL Function.

Authors:  Courtney L Millar; Quinn Duclos; Christopher N Blesso
Journal:  Adv Nutr       Date:  2017-03-15       Impact factor: 8.701

9.  Isorhamnetin ameliorates LPS-induced inflammatory response through downregulation of NF-κB signaling.

Authors:  Yang Li; Gefu Chi; Bingyu Shen; Ye Tian; Haihua Feng
Journal:  Inflammation       Date:  2016-08       Impact factor: 4.092

10.  Plant flavonol isorhamnetin attenuates chemically induced inflammatory bowel disease via a PXR-dependent pathway.

Authors:  Wei Dou; Jingjing Zhang; Hao Li; Sandhya Kortagere; Katherine Sun; Lili Ding; Gaiyan Ren; Zhengtao Wang; Sridhar Mani
Journal:  J Nutr Biochem       Date:  2014-05-09       Impact factor: 6.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.